Precise offers its clients a unique, cost-effective advantage -- the ability to pull resources on demand from our subsidiary, Xemplar Pharmaceuticals. If strict processes and testing are needed, we can provide a preferred level of service.

Xemplar provides highly sophisticated formulation and product development services to meet our clients' precise needs. Xemplar’s broad scientific and industry experience ensures they can effectively develop and analyze a wide range of pharmaceutical and biopharmaceutical products.

Services available through our relationship with Xemplar: Professional Expertise State-of-the-art formulation and analytical facilities cGMP and GMP production Analytical, Formulation, and Stability Testing for aerosol products Device Optimization and Testing Product Comparisons In Vitro BA/BE Testing Regulatory Support: IND, NDA, ANDA Product Stability Testing Process Development Support Clinical and Toxicology Supplies Degradants, Impurities Identification and Supplies

The cornerstone of Xemplar’s business is its unique ability to provide cGMP supplies for clinical Phase I and Phase II studies as well as for stability and performance evaluation. Visit them at www.xemplarpharm.com

Xemplar is among the first commercial facilities in the world to offer inhalation development services. Xemplar is also the sole representative of Pharmask Inc. of Medfield, MA, which has developed a device that consists of a multi-part, snap together, injection molded plastic cloak which hides the canister and the MDI applicator as a means of concealing the identity of metered dose aerosol drugs and placebos while in clinical trial use. It has been designed so that it is easily assembled, yet very difficult to take apart.